Purchase Order HHSF223201400813P
Award Date 9/10/14
Potential Completion Date 9/30/15
Potential Value $24K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Danvers, MA 01923, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency under the National Institutes of Health (NIH), to Cell Signaling Technology, Inc., a for-profit manufacturer of scientific research products. The $24,873.36 contract is for the delivery of antibodies to support ongoing experiments at NIDA's lab. No set-aside designation was used for this award. Cell Signaling Technology, Inc. has a history of securing NIH contract awards to...
- This firm fixed price purchase order contract was awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Cell Signaling Technology, Inc. (CST) to conduct global TMT profiling analysis services. The $52,000 award has a period of performance through September 24, 2025. The contract is based on a solicitation from the National Heart, Lung and Blood Institute seeking quantitative proteomic analysis of paired FBXW7-mutant...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $102,000.00 firm fixed price purchase order to Cell Signaling Technology, Inc. to provide PTMScan Ubiquitin Standard Service. This contract has no set-aside designation. Cell Signaling Technology is a private, family-owned company that develops and produces antibodies, kits, and reagents used to study cell signaling pathways, with a focus on applied systems biology...
- This is a $3,800 fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Cell Signaling Technology, Inc. (CST). The contract is for TAS service work order. CST is a private, for-profit company that specializes in developing and producing antibodies, kits, and reagents for applied systems biology research related to cancer. CST has previously provided proteomic analysis, mass...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Department of Health and Human Services (HHS) to Cell Signaling Technology, Inc. (CST), a private, family-owned company that develops and produces antibodies, kits, and reagents for cell signaling research. The $150,000.00 firm fixed price contract is for the detection of oncogenic targets using a multiplex bead enzyme-linked immunosorbent assay (ELISA). The contract has a total small business set aside...
- This is a $95,200 firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Cell Signaling Technology, Inc. (CST) for proteomic characterization of FBXW7-mutant CRISPR-edited uterine cancer cells. The contract has no set-aside designation and was awarded on January 24, 2019 with a completion date of April 23, 2020. CST is a private, family-owned company that provides specialized...
- This is a $90,324.00 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Nanion Technologies Inc., a small business vendor. The contract is for the provision of a Real Time Cell Analysis Cardio System to support the monitoring of drug-induced cardiotoxicity. The system will be used to perform advanced cellular research and drug discovery studies at the FDA's facilities in Silver Spring, Maryland. The contract was set aside for small business competition,...
- <p>This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Cellular Technology LIMITED, a self-certified small disadvantaged business. The contract, valued at $53,170.00, is for the purchase of DARS laboratory supplies and consumables. The contract has an ultimate completion date of August 31, 2026 and was awarded on August 12, 2025. The contract does not have a set-aside designation.</p>
- The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Human Genome Research Institute awarded a firm fixed-price purchase order to Cell Signaling Technology, Inc. (CST), a private, for-profit manufacturing company, to provide proteomic characterization of FBXW7-mutant CRISPR-edited uterine cancer cells. The award, valued at $148,500.00, did not have a set-aside designation and was completed on August 15, 2020. CST has previously provided proteome...
- This is a firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract has a ceiling value of $3,440.90 and a completion date of July 6, 2011. The contract is for "TAS::75 0600::TAS SFM MEDIUM" and does not have a set-aside designation. Life Technologies Corporation serves as a prime contractor across various federal agencies, including the National...